Company
Edesa Biotech
Novel Experimental Treatments for Immune and Inflammatory Diseases
Also known as Edesa Biotech Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Markham, Ontario, Canada
- Legal name
- Edesa Biotech Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
We are a clinical-stage biopharmaceutical company exploring new ways to treat inflammatory and immune-related diseases.
Funding snapshot
- Total raised
- $40.4MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $3.5M2026-06-16
Funding rounds
- Round, 2026
- $3.5M2026-06-16, SEC form D sold, 4 investors
- Round, 2025
- $15M2025-02-12, SEC form D sold, 15 investors
- Round, 2022
- 2022-03-211 investor
- Round, 2016
- $6.8M2016-07-06, SEC form D sold, 4 investors
- Round, 2013
- $12M2013-09-09, SEC form D sold, 50 investors
- Round, 2013
- $1.6M2013-04-03, SEC form D sold, 22 investors
- Round, 2013
- $505K2013-01-02, SEC form D sold, 9 investors
- Round, 2012
- $1M2012-10-25, SEC form D sold, 3 investors
Loading relationship preview